A Phase I, Randomized, Placebo-controlled, Single-center Study to Assess the Safety, Tolerability, and Pharmacokinetics of AZD0914 After a Single Oral Administration and to Assess the Effect of Food in Healthy Adult Volunteers
Phase of Trial: Phase I
Latest Information Update: 29 Oct 2018
Price : $35 *
At a glance
- Drugs Zoliflodacin (Primary)
- Indications Gonorrhoea
- Focus Adverse reactions
- Sponsors AstraZeneca
- 29 Oct 2018 Results from two phase I trials (NCT02298920 and NCT01929629 ) published in the Antimicrobial Agents and Chemotherapy.
- 18 Mar 2014 The study title and treatments have been updated to exclude the multiple dose administration of AZD0914, according to a ClinicalTrials.gov record.
- 18 Mar 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.